Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/09/2022 | 26.39% | Raymond James | $48 → $42 | Maintains | Outperform |
09/14/2022 | 38.43% | Argus Research | → $46 | Upgrades | Hold → Buy |
09/06/2022 | 62.5% | Wells Fargo | → $54 | Upgrades | Equal-Weight → Overweight |
05/04/2022 | 44.45% | Raymond James | $55 → $48 | Maintains | Outperform |
11/11/2021 | 65.51% | Raymond James | $59 → $55 | Maintains | Outperform |
10/14/2021 | 77.55% | Raymond James | → $59 | Upgrades | Market Perform → Outperform |
09/30/2021 | 89.59% | Jefferies | $45 → $63 | Upgrades | Hold → Buy |
03/05/2021 | 35.42% | Morgan Stanley | $53 → $45 | Maintains | Equal-Weight |
01/06/2021 | 47.46% | RBC Capital | $59 → $49 | Downgrades | Outperform → Sector Perform |
10/28/2020 | 47.46% | Wells Fargo | $55 → $49 | Maintains | Equal-Weight |
09/17/2020 | 89.59% | SVB Leerink | $64 → $63 | Maintains | Outperform |
06/08/2020 | 89.59% | SVB Leerink | $55 → $63 | Maintains | Outperform |
04/17/2020 | — | Argus Research | Downgrades | Buy → Hold | |
04/02/2020 | 59.49% | Morgan Stanley | $54 → $53 | Maintains | Equal-Weight |
03/24/2020 | 71.53% | JP Morgan | → $57 | Upgrades | Neutral → Overweight |
03/20/2020 | 56.49% | SVB Leerink | $54 → $52 | Upgrades | Market Perform → Outperform |
03/11/2020 | 59.49% | Wells Fargo | $63 → $53 | Maintains | Equal-Weight |
01/21/2020 | 110.65% | Cantor Fitzgerald | $60 → $70 | Maintains | Overweight |
10/11/2019 | — | Argus Research | Upgrades | Hold → Buy | |
09/30/2019 | 56.49% | Wells Fargo | $45 → $52 | Maintains | Market Perform |
09/25/2019 | 65.51% | SunTrust Robinson Humphrey | $51 → $55 | Maintains | Hold |
03/26/2019 | 62.5% | Morgan Stanley | $67 → $54 | Maintains | Equal-Weight |
03/20/2019 | 53.48% | SunTrust Robinson Humphrey | → $51 | Initiates Coverage On | → Hold |
12/21/2018 | 38.43% | Wells Fargo | $64 → $46 | Maintains | Market Perform |
11/13/2018 | 101.63% | Morgan Stanley | $77 → $67 | Maintains | Equal-Weight |
11/13/2018 | 116.67% | Berenberg | $100 → $72 | Downgrades | Buy → Hold |
08/21/2018 | 131.72% | Wells Fargo | $84 → $77 | Maintains | Market Perform |
08/10/2018 | 101.63% | RBC Capital | $89 → $67 | Maintains | Sector Perform |
08/10/2018 | 125.7% | JP Morgan | $83 → $75 | Maintains | Neutral |
08/10/2018 | 134.73% | Deutsche Bank | $93 → $78 | Downgrades | Buy → Hold |
07/30/2018 | — | Argus Research | Downgrades | Buy → Hold | |
07/12/2018 | 122.69% | Goldman Sachs | $78 → $74 | Downgrades | Neutral → Sell |
06/06/2018 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
05/14/2018 | 152.78% | Wells Fargo | $90 → $84 | Maintains | Market Perform |
03/05/2018 | 149.77% | JP Morgan | $82 → $83 | Maintains | Neutral |
02/01/2018 | 252.09% | Berenberg | → $117 | Initiates Coverage On | → Buy |
01/03/2018 | 170.84% | Leerink Swann | → $90 | Initiates Coverage On | → Market Perform |
12/08/2017 | — | Argus Research | Upgrades | Hold → Buy | |
11/10/2017 | 176.86% | Morgan Stanley | $79 → $92 | Maintains | Equal-Weight |
11/10/2017 | — | RBC Capital | Upgrades | Underperform → Market Perform |
Perrigo Questions & Answers
The latest price target for Perrigo (NYSE: PRGO) was reported by Raymond James on November 9, 2022. The analyst firm set a price target for $42.00 expecting PRGO to rise to within 12 months (a possible 26.39% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Perrigo (NYSE: PRGO) was provided by Raymond James, and Perrigo maintained their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Perrigo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Perrigo was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
While ratings are subjective and will change, the latest Perrigo (PRGO) rating was a maintained with a price target of $48.00 to $42.00. The current price Perrigo (PRGO) is trading at is $33.23, which is out of the analyst's predicted range.